Interventional technology firm Medtronic has received approval for its Endeavor drug-eluting coronary stent system by the Japanese Ministry of Health, Labour, and Welfare.
The Minneapolis-based firm said it would launch Endeavor in Japan immediately following reimbursement authorization, which is expected on May 1.
Related Reading
Medtronic poses revision for CMS NCD, March 17, 2009
Medtronic completes stent safety study enrollment, February 2, 2009
Boston Scientific, Medtronic bury the hatchet, January 28, 2009
Medtronic installs MRI system in Canada, January 13, 2009
Medtronic gets CE Mark for MRI pacemaker, November 17, 2008
Copyright © 2009 AuntMinnie.com